BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 17, 2026

  September 17, 2026

   · 

  2 min read
• Press Releases

  argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors

  September 17, 2026

   · 

  1 min read
• Press Releases

  Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program

  September 17, 2026

   · 

  11 min read
• Press Releases

  Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 17, 2026

  September 17, 2026

   · 

  4 min read
• Press Releases

  Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors

  September 17, 2026

   · 

  4 min read
• Press Releases

  Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer

  September 17, 2026

   · 

  5 min read
• Press Releases

  Marvel Biosciences Provides Update on Private Placement for up to $3.0 Million

  September 17, 2026

   · 

  8 min read
• Press Releases

  Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum

  September 17, 2026

   · 

  1 min read
• Press Releases

  Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch

  September 17, 2026

   · 

  4 min read